Retrospective Analysis of Adoptive TIL Therapy plus Anti-PD1 Therapy in Patients with Chemotherapy-Resistant Metastatic Osteosarcoma

Table 4

Univariate analysis of factors related to mDFS and mOS of patients in this study ().

Characteristics	mDFS (months)	value	mOS (months)	value
Gender
Male	5.75		13.5
Female	5.55	0.838	15.5	0.111
Age (years)
≥20	5.25		12.9
<20	5.9	0.375	14.5	0.518
ECOG PS
0	5.75		14.2
1	5.75	0.496	12.9	0.985
Site of primary tumor
Femur and tibia	5.75		13.5
Other	5.6	0.425	15.3	0.424
Size of primary tumor (cm)
≥5	5.55		13.6
<5	6.2	0.87	14.0	0.668
Response to neoadjuvant chemotherapy
Good	5.9		14.5
Poor	5.2	0.242	13.5	0.566
Location of metastasis
Lung	5.6		15.1
Others	6.0	0.482	13.6	0.167